MFGE8 and colorectal cancer: Furthermore, higher miR-26a expression levels, and lower miR-124-5p expression levels were associated with a lower probability of OS; therefore the expression of MFGE8, miR-26a and miR-124-5p in plasma may be used as biomarkers to determine the prognosis of colorectal cancer patients.